Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes

OBJECTIVE: Agents that augment GLP-1 effects enhance glucose-dependent β-cell insulin production and secretion and thus are hoped to prevent progressive impairment in insulin secretion characteristic of type 2 diabetes (T2D). The purpose of this study was to evaluate GLP-1 effects on β-cell secretor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudipaty, Lalitha, Rosenfeld, Nora K., Fuller, Carissa S., Gallop, Robert, Schutta, Mark H., Rickels, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140159/
https://www.ncbi.nlm.nih.gov/pubmed/24969577
http://dx.doi.org/10.2337/dc14-0398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140159/
https://www.ncbi.nlm.nih.gov/pubmed/24969577
http://dx.doi.org/10.2337/dc14-0398

Ejemplares similares